State Street’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
MAP
State Street's INDV Position: Q2 2026 in Review
State Street increased its Indivior Pharmaceuticals (INDV) stake by 1.8% in Q2 2026, buying an estimated $3.2M and bringing the position to 4,992,071 shares worth $205M. The position accounts for 0.01% of the portfolio, ranked #1038.
State Street first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- State Street held 4,992,071 shares of Indivior Pharmaceuticals worth $205M as of Q2 2026.
- State Street bought 88,078 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.2M.
- Indivior Pharmaceuticals made up 0.01% of State Street's portfolio in Q2 2026, its #1038 holding.
- State Street first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
- 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.